Here, we review the most recent findings on the Crimean–Congo hemorrhagic fever virus molecular biology and pathogenesis, including aspects of virus–host cell interactions. To date ...

It causes hemorrhagic fever, which is an especially dangerous disease. The fatality rate can reach up to 88%, according to ...

As dengue has become a greater threat to public health, scientists have made progress in their search for dengue fever treatments ... Understanding dengue pathogenesis: Implications for vaccine ...

Discover how the EASTAR nomogram improves prognosis for hantavirus patients, aiding clinicians in risk stratification and ...

After more than 20 years of research on arenaviruses, an Institut Pasteur team led by Sylvain Baize has developed an original vaccine platform known as MOPEVAC, which will strengthen the Institut ...

Known as severe fever with thrombocytopenia syndrome, or SFTS, the highly fatal viral hemorrhagic fever spreads to humans through ixodid ticks, which are typically found in mountains, forests and ...

Perspective from Robert F Garry Jr., PhD The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which ...

[66] Crimean–Congo hemorrhagic fever virus (CCHFV ... Cytokines are most probably involved in the pathogenesis of CCHFV disease. CCHFV has evolved a novel strategy to escape recognition by ...